AMP-224
AMP-224 is a fusion protein targeting PD-L2. AMP-224 specifically binds to PD-1 T cells (chronically stimulated/exhausted T cells) . AMP-224 can be used in Colorectal cancer and Solid tumours research[1].
Product Specifications
UNSPSC
12352203
Target
PD-1/PD-L1
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Smiles
[AMP-224]
References & Citations
[1]Duffy A G, et al. A pilot study of AMP-224, a PD-L2 Fc fusion protein, in combination with stereotactic body radiation therapy (SBRT) in patients with metastatic colorectal cancer[J]. 2016.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
bsm-41663M-BF555 100 µL
VEGFA/VEGF165 Monoclonal Antibody, AbBy Fluor™ 555 Conjugated
Ask
View Details GTR15324184 1 Vial
Lentiviral human REEP2 shRNA (UAS) - Lentiviral human REEP2 shRNA (UAS, RFP) plasmid
Ask
View Details